Decompressive Percutaneous Endoscopic Gastrostomy in Advanced Cancer Patients with Small-bowel Obstruction is Feasible and Effective: a Large Prospective Study

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2016 Feb 4

PMID 26838026

Citations 18

Authors

Elena Zucchi

Mara Fornasarig

Luca Martella

Stefania Maiero

Emilio Lucia

Eugenio Borsatti

Luca Balestreri

Giorgio Giorda

Maria Antonietta Annunziata

Renato Cannizzaro

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study was to evaluate patient-centered outcomes of decompressive percutaneous endoscopic gastrostomy (dPEG) in patients with malignant bowel obstruction due to advanced gynecological and gastroenteric malignancies.

Methods: This is a prospective analysis of 158 consecutive patients with small-bowel obstruction from advanced gynecological and gastroenteric cancer who underwent PEG or percutaneous endoscopic jejunostomy (PEJ) positioning for decompressive purposes from 2002 to 2012. All of them had previous abdominal surgery and were unfit for any other surgical procedures. Symptom relief, procedural complications, and post dPEG palliation were assessed. Global Quality of Life (QoL) was evaluated in the last 2 years (25 consecutive patients) before and 7 days after dPEG placement using the Symptom Distress Scale (SDS).

Results: dPEG was successfully performed in 142 out of 158 patients (89.8 %). Failure of tube placement occurred in 16 patients (10.1 %). In 8/142 (5.6 %) patients, dPEG was guided by abdominal ultrasound. In 3/142 patients, dPEG was CT-guided. In 14 (9.8 %) patients, who had previously undergone total or subtotal gastrectomy, decompressive percutaneous endoscopic jejunostomy (dPEJ) was performed. In 1/14 patients, dPEJ was CT-guided. Out of 142 patients, 110 (77.4 %) experienced relief from nausea and vomiting 2 days after PEG. Out of 142 patients, 116 (81.6 %) were discharged. The median postoperative hospital stay was 9 days (range 3-60). Peristomal infection (14 %) and intermittent obstruction (8.4 %) were the most frequent complications associated with PEG. Median survival time was 57 days (range 4-472) after PEG placement. Twenty-five patients had QoL properly evaluated with SDS score before and 7 days after dPEG. Sixteen patients (64 %) out of 25 exhibited an improvement of QoL (p < 0.05), 7 (28 %) patients exhibited a non-significant worsening of QoL (p = 0.18), and in 2 (8 %) patients, it remained unmodified.

Conclusions: dPEG is feasible, effective, relieves nausea and vomiting in patients with unremitting small-bowel obstruction from advanced gynecological and gastroenteric cancer, and improves QoL.

Citing Articles

Feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) in advanced cancer patients with malignant bowel obstruction.

Wanzl J, Hofer S, Schwamberger T, Tadic V, Muzalyova A, Hainsch-Muller I Endosc Int Open. 2024; 12(11):E1411-E1416.

PMID: 39610950 PMC: 11604304. DOI: 10.1055/a-2458-9919.

Management of Malignant Bowel Obstruction in Patients with Gynaecological Cancer: A Systematic Review.

Toth R, Toth Z, Loczi L, Torok M, Acs N, Varbiro S J Clin Med. 2024; 13(14).

PMID: 39064252 PMC: 11277705. DOI: 10.3390/jcm13144213.

Inoperable malignant bowel obstruction: palliative interventions outcomes - mixed-methods systematic review.

Patterson M, Greenley S, Ma Y, Bullock A, Curry J, Smithson J BMJ Support Palliat Care. 2024; 13(e3):e515-e527.

PMID: 38557409 PMC: 10850628. DOI: 10.1136/bmjspcare-2021-003492.

CT Fluoroscopy-Guided Percutaneous Gastrostomy in the Palliative Management of Advanced and Relapsed Ovarian Cancer: The Charité Experiences and a Review of the Literature.

Canaz E, Sehouli J, Gebauer B, Segger L, Collettini F, Auer T Cancers (Basel). 2023; 15(18).

PMID: 37760510 PMC: 10526206. DOI: 10.3390/cancers15184540.

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial.

Krouse R, Anderson G, Arnold K, Thomson C, Nfonsam V, Al-Kasspooles M Lancet Gastroenterol Hepatol. 2023; 8(10):908-918.

PMID: 37541263 PMC: 10530384. DOI: 10.1016/S2468-1253(23)00191-7.

References

Kawata N, Kakushima N, Tanaka M, Sawai H, Imai K, Hagiwara T . Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction. Dig Endosc. 2013; 26(2):208-13. DOI: 10.1111/den.12139. View

Stellato T, Gauderer M . Percutaneous endoscopic gastrostomy for gastrointestinal decompression. Ann Surg. 1987; 205(2):119-22. PMC: 1492828. DOI: 10.1097/00000658-198702000-00002. View

McClave S, Ritchie C . The role of endoscopically placed feeding or decompression tubes. Gastroenterol Clin North Am. 2006; 35(1):83-100. DOI: 10.1016/j.gtc.2005.12.003. View

Ripamonti C, Mercadante S . How to use octreotide for malignant bowel obstruction. J Support Oncol. 2004; 2(4):357-64. View

Laval G, Arvieux C, Stefani L, Villard M, Mestrallet J, Cardin N . Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage. 2006; 31(6):502-12. DOI: 10.1016/j.jpainsymman.2005.10.009. View

VOGT W, Messmann H, Lock G, Gmeinwieser J, Feuerbach S, Scholmerich J . CT-guided PEG in patients with unsuccessful endoscopic transillumination. Gastrointest Endosc. 1996; 43(2 Pt 1):138-40. DOI: 10.1016/s0016-5107(06)80116-1. View

Shike M, Wallach C, Likier H . Direct percutaneous endoscopic jejunostomies. Gastrointest Endosc. 1991; 37(1):62-5. DOI: 10.1016/s0016-5107(91)70625-1. View

Mercadante S, Porzio G . Octreotide for malignant bowel obstruction: twenty years after. Crit Rev Oncol Hematol. 2012; 83(3):388-92. DOI: 10.1016/j.critrevonc.2011.12.006. View

Panzer S, Harris M, Berg W, Ravich W, Kalloo A . Endoscopic ultrasound in the placement of a percutaneous endoscopic gastrostomy tube in the non-transilluminated abdominal wall. Gastrointest Endosc. 1995; 42(1):88-90. DOI: 10.1016/s0016-5107(95)70253-9. View

10.

Clarke-Pearson D, Chin N, DeLong E, Rice R, Creasman W . Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol. 1987; 26(1):11-8. DOI: 10.1016/0090-8258(87)90066-7. View

11.

Storey P . Obstruction of the GI tract. Am J Hosp Palliat Care. 1991; 8(3):5. DOI: 10.1177/104990919100800310. View

12.

Pothuri B, Montemarano M, Gerardi M, Shike M, Ben-Porat L, Sabbatini P . Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol. 2005; 96(2):330-4. DOI: 10.1016/j.ygyno.2004.09.058. View

13.

Shike M, Wallach C, Bloch A, Brennan M . Combined gastric drainage and jejunal feeding through a percutaneous endoscopic stoma. Gastrointest Endosc. 1990; 36(3):290-2. DOI: 10.1016/s0016-5107(90)71026-7. View

14.

Tsahalina E, Woolas R, Carter P, Chan F, Gore M, Blake P . Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction. Br J Obstet Gynaecol. 1999; 106(9):964-8. DOI: 10.1111/j.1471-0528.1999.tb08438.x. View

15.

Mangili G, Franchi M, Mariani A, Zanaboni F, Rabaiotti E, Frigerio L . Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol. 1996; 61(3):345-8. DOI: 10.1006/gyno.1996.0154. View

16.

Scheidbach H, Horbach T, Groitl H, Hohenberger W . Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas. Surg Endosc. 1999; 13(11):1103-5. DOI: 10.1007/s004649901182. View

17.

Malone Jr J, Koonce T, Larson D, Freedman R, Carrasco C, Saul P . Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol. 1986; 68(3):431-3. DOI: 10.1097/00006250-198609000-00030. View

18.

Gauderer M, Ponsky J, IZANT Jr R . Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg. 1980; 15(6):872-5. DOI: 10.1016/s0022-3468(80)80296-x. View

19.

Vargo J, Germain M, SWENSON J, HARRISON C . Ultrasound-assisted percutaneous endoscopic gastrostomy in a patient with advanced ovarian carcinoma and recurrent intestinal obstruction. Am J Gastroenterol. 1993; 88(11):1946-8. View

20.

Chu D, Lang N, Thompson C, Osteen P, Westbrook K . Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989; 63(2):364-7. DOI: 10.1002/1097-0142(19890115)63:2<364::aid-cncr2820630228>3.0.co;2-v. View